1-20 of 39
Aniko Szabo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter Study to Assess the Outcomes and Prognosis of Richter's Transformation in the Era of Novel Agents and Cell Therapy

Fateeha Furqan, Katelin Baird, Merve Kacar, Annika S Surapaneni, Ulrich Kemmo Tsafack, Aniko Szabo, Jakub Svoboda, Brian T. Hill, Jason T. Romancik, Nirav N. Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4486.
https://doi.org/10.1182/blood-2023-186703
Published: 2023
Journal Articles

A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with CD38 Expressing Relapsed/Refractory Acute Myeloid Leukemia

Guru Subramanian Guru Murthy, Jessica T. Leonard, Talha Badar, Cecilia Y. Arana Yi, Adam S Duvall, Bijal D. Shah, Arielle Baim, Tyce Kearl, Alexandra M. Harrington, Aniko Szabo, Ehab L. Atallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 1541.
https://doi.org/10.1182/blood-2023-187721
Published: 2023
Journal Articles

Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

Meera Mohan, Nishi Shah, Danny Luan, Jorge Monge, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis L Cooper, Suzanne Lentzsch, Frits van Rhee, Anita D'Souza, Aniko Szabo, Carolina Schinke, Rajshekhar Chakraborty
Journal: Blood
Blood (2023) 142 (Supplement 1): 545.
https://doi.org/10.1182/blood-2023-174875
Published: 2023
Journal Articles

A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Guru Subramanian Guru Murthy, Bijal D. Shah, Adam S Duvall, Jessica T. Leonard, Talha Badar, Cecilia Y. Arana Yi, Tyce Kearl, Arielle Baim, Alexandra M. Harrington, Aniko Szabo, Ehab L. Atallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4242.
https://doi.org/10.1182/blood-2023-187468
Published: 2023
Journal Articles

The Effect of Stem Cell Infusion on Immune Effector Cell Associated Hematotoxicity with BCMA CAR T in Multiple Myeloma

Anannya Patwari, Tanvi H. Patel, Ramya Bachu, Jean Esselmann, Lisa Rein, Aniko Szabo, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine E. Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Binod Dhakal, Anita D'Souza, Meera Mohan, Carolina Schinke
Journal: Blood
Blood (2023) 142 (Supplement 1): 758.
https://doi.org/10.1182/blood-2023-186697
Published: 2023
Journal Articles

Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)

Binod Dhakal, Meera Mohan, Ravi Narra, Katie Palen, Aniko Szabo, Tyce Kearl, Gayathri Ravi, Susan Bal, Bryon D. Johnson, Marcelo Pasquini, Anita D'Souza, Parameswaran N. Hari, Luciano Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 3379.
https://doi.org/10.1182/blood-2023-181266
Published: 2023
Journal Articles

Adaptive Manufacturing of LV20.19 CAR T-Cells for Relapsed, Refractory Mantle Cell Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Tyce Kearl, Anthony Zamora, Jessica Neumann, Parameswaran N. Hari, Dina Schneider, Walter Longo, Peiman Hematti, Bryon D. Johnson, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood
Blood (2023) 142 (Supplement 1): 1024.
https://doi.org/10.1182/blood-2023-173954
Published: 2023
Journal Articles

Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Secondary Central Nervous System Large B-Cell Lymphoma (SCNSL): A Multicenter Retrospective Analysis

Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Alexandra E. Rojek, Peter A. Riedell, Farrukh T. Awan, Laura Samples, Mazyar Shadman, Marie Hu, Veronika Bachanova, William Wesson, Nausheen Ahmed, Madiha Iqbal, Mohamed A. Kharfan-Dabaja, Michael Scordo, Patrick Connor Johnson, Yi-Bin Chen, Sawa Ito, Mehdi Hamadani, Matthew J. Frigault
Journal: Blood
Blood (2023) 142 (Supplement 1): 3088.
https://doi.org/10.1182/blood-2023-184345
Published: 2023
Journal Articles

Does Socioeconomic Status Have an Impact on Light Chain (AL) Amyloidosis Disease Characteristics and Outcomes?

Mingqian Lin, Aniko Szabo, Liliana Pezzin, Jing Dong, Binod Dhakal, Meera Mohan, Ravi Narra, Marcelo Pasquini, Anita D'Souza
Journal: Blood
Blood (2023) 142 (Supplement 1): 4783.
https://doi.org/10.1182/blood-2023-186740
Published: 2023
Journal Articles

Blood and Marrow Transplantation (BMT) within Four Weeks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study

Meera Mohan, Nathaniel Verhagen, Aditya Shreenivas, Sabarinath Radhakrishnan, Binod Dhakal, Saurabh Chhabra, Michael A. Thompson, Marcelo C Pasquini, Anita D'Souza, Mehdi Hamadani, Aniko Szabo, Anai Kothari
Journal: Blood
Blood (2022) 140 (Supplement 1): 940–941.
https://doi.org/10.1182/blood-2022-165413
Published: 2022
Journal Articles

Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy

Samer Al Hadidi, Aniko Szabo, Jean Esselmann, Lindsay Hammons, Munawwar Hussain, Yetunde Ogunsesan, Nishanth Thalambedu, Fatima Khan, Jaskirat Sethi, Abhishek Janardan, Sabarinath Radhakrishnan, Sharmilan Thanendrarajan, Carolina Schinke, Binod Dhakal, Siegfried Janz, Saurabh Chhabra, Anita D'Souza, Maurizio Zangari, Frits van Rhee, Meera Mohan
Journal: Blood
Blood (2022) 140 (Supplement 1): 8038–8039.
https://doi.org/10.1182/blood-2022-168794
Published: 2022
Journal Articles

Results from a Phase 1/2 Study of Tandem, Bispecific Anti-CD20/Anti-CD19 (LV20.19) CAR T-Cells for Mantle Cell Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Jessica Neumann, Parameswaran Hari, Dina Schneider, Bryon Johnson, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood
Blood (2022) 140 (Supplement 1): 9318–9319.
https://doi.org/10.1182/blood-2022-158695
Published: 2022
Journal Articles

Assessment of Comorbidities and Their Association with Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL)Using Various Comorbidity-Based Scoring Systems

Ravi Kishore Narra, Ehab L. Atallah, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Aniko Szabo, Guru Subramanian Guru Murthy
Journal: Blood
Blood (2022) 140 (Supplement 1): 6035–6036.
https://doi.org/10.1182/blood-2022-165392
Published: 2022
Journal Articles

Differences in Light Chain (AL) Amyloidosis Epidemiology By Race and Ethnicity

Ashima Singh, Aniko Szabo, Qinghua Lian, Purushottam Laud, Liliana Pezzin, Anita D'Souza
Journal: Blood
Blood (2022) 140 (Supplement 1): 4366–4368.
https://doi.org/10.1182/blood-2022-170304
Published: 2022
Journal Articles

8-Day Versus 12-Day Manufactured LV20.19 CAR T-Cells for B-Cell Non-Hodgkin Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Jessica Neumann, Walter L. Longo, Parameswaran Hari, Dina Schneider, Bryon Johnson, Timothy S. Fenske, Mehdi Hamadani
Journal: Blood
Blood (2022) 140 (Supplement 1): 7480–7481.
https://doi.org/10.1182/blood-2022-169119
Published: 2022
Journal Articles

Lintuzumab-Ac225 with Combination with Intensive Chemotherapy Yields High Response Rate and MRD Negativity in R/R AML with Adverse Features

Sameem Abedin, Guru Subramanian Guru Murthy, Aniko Szabo, Mehdi Hamadani, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Katelyn Gauger, Avinash G Desai, Mary M Chen, Alexandra M. Harrington, Ehab L. Atallah
Journal: Blood
Blood (2022) 140 (Supplement 1): 157–158.
https://doi.org/10.1182/blood-2022-157827
Published: 2022
Journal Articles

Associations between Socioeconomic Status and Bispecific LV20.19 CAR T-Cell Therapy Outcomes

Edward Paul Hackett, Nirav N. Shah, Cecilia Hillard, Elizabeth Aughey, Rachel Cusatis, Aniko Szabo, Jennifer M Knight
Journal: Blood
Blood (2021) 138 (Supplement 1): 4084.
https://doi.org/10.1182/blood-2021-146665
Published: 2021
Journal Articles

A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma

Guru Subramanian Guru Murthy, Tyce J Kearl, Weiguo Cui, Bryon Johnson, Karin Hoffmeister, Aniko Szabo, Kazuhiro Aoki, Alexandra M. Harrington, Karen Carlson, Laura C. Michaelis, Lyndsey Runaas, Sameem Abedin, Adam S Duvall, Wendy Stock, Bijal D. Shah, Jessica Leonard, Keith W. Pratz, Selina M. Luger, Talha Badar, Arielle Baim, Shahriar Yaghoubi, Ehab L. Atallah
Journal: Blood
Blood (2021) 138 (Supplement 1): 4401.
https://doi.org/10.1182/blood-2021-149329
Published: 2021
Journal Articles

Outcomes of Primary Bone Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Multicenter Retrospective Analysis

Alexandra Rezazadeh, Aniko Szabo, Kathleen Monahan, Arushi Khurana, David J. Inwards, Matthew A. Lunning, Amanda Cashen, Nancy L. Bartlett, Paolo F. Caimi, Thomas D. Rodgers, Paul M. Barr, Sayan Mullick Chowdhury, Narendranath Epperla, Hiruni Mendries, Brian T. Hill, Timothy Seijung Oh, Reem Karmali, Julie E. Chang, Gaurav Goyal, Benjamin M Parsons, Krista M. Isaac, Craig A. Portell, Malika Siker, David M King, Timothy S. Fenske
Journal: Blood
Blood (2021) 138 (Supplement 1): 1451.
https://doi.org/10.1182/blood-2021-145145
Published: 2021
Journal Articles

A Phase I Study of Pevonedistat, Azacitidine and Venetoclax for Patients with Relapsed/Refractory Acute Myelogenous Leukemia (AML)

Guru Subramanian Guru Murthy, Scott H. Kaufmann, Aniko Szabo, Alexandra M. Harrington, Laura C. Michaelis, Sameem Abedin, Karen Carlson, Lyndsey Runaas, Walter L. Longo, Alexander Hinman, Sonia Maldonado-Schmidt, Althea Thomas, Arielle Baim, Mark R. Litzow, Ehab L. Atallah
Journal: Blood
Blood (2021) 138 (Supplement 1): 2347.
https://doi.org/10.1182/blood-2021-149351
Published: 2021